BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8995186)

  • 21. CD72-mediated suppression of human naive B cell differentiation by down-regulating X-box binding protein 1.
    Yamazaki T; Nagumo H; Hayashi T; Sugane K; Agematsu K
    Eur J Immunol; 2005 Aug; 35(8):2325-34. PubMed ID: 16047337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα.
    Kataoka TR; Kumanogoh A; Fukuishi N; Ueshima C; Hirata M; Moriyoshi K; Tsuruyama T; Haga H
    Int Immunol; 2015 Feb; 27(2):95-103. PubMed ID: 25239131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human CD72 splicing isoform responsible for resistance to systemic lupus erythematosus regulates serum immunoglobulin level and is localized in endoplasmic reticulum.
    Hitomi Y; Adachi T; Tsuchiya N; Honda Z; Tokunaga K; Tsubata T
    BMC Immunol; 2012 Dec; 13():72. PubMed ID: 23268649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5.
    Bikah G; Lynd FM; Aruffo AA; Ledbetter JA; Bondada S
    Int Immunol; 1998 Aug; 10(8):1185-96. PubMed ID: 9723705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A unique CD72 epitope suggests a potential interaction with Fc gamma RII/CD32 on B lineage lymphocytes.
    Yamashita Y; Phee H; Tudor KS; Rossi MI; Parnes JR; Coggeshall KM; Kincade PW
    Hybridoma (Larchmt); 2006 Jun; 25(3):107-14. PubMed ID: 16796456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation.
    Pan C; Baumgarth N; Parnes JR
    Immunity; 1999 Oct; 11(4):495-506. PubMed ID: 10549631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human peripheral blood T helper cell-induced B cell activation results in B cell surface expression of the CD23 (BLAST-2) antigen.
    Crow MK; Kushner B; Jover JA; Friedman SM; Mechanic SE; Stohl W
    Cell Immunol; 1989 Jun; 121(1):99-112. PubMed ID: 2524281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of CD72 expression on CD19
    Lyu M; Hao Y; Li Y; Lyu C; Liu W; Li H; Xue F; Liu X; Yang R
    Br J Haematol; 2017 Jul; 178(2):308-318. PubMed ID: 28419421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of B lymphocytes via CD72 (human Lyb-2).
    Kamal M; Katira A; Gordon J
    Eur J Immunol; 1991 Jun; 21(6):1419-24. PubMed ID: 1828426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel avian homologue of CD72, chB1r, down modulates BCR-mediated activation signals.
    Fujiwara N; Hidano S; Mamada H; Ogasawara K; Kitamura D; Cooper MD; Hozumi N; Chen CL; Goitsuka R
    Int Immunol; 2006 May; 18(5):775-83. PubMed ID: 16581823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD72 negatively regulates signaling through the antigen receptor of B cells.
    Adachi T; Wakabayashi C; Nakayama T; Yakura H; Tsubata T
    J Immunol; 2000 Feb; 164(3):1223-9. PubMed ID: 10640734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of the mouse CD72 (Lyb-2) gene and its alternatively spliced transcripts.
    Ying H; Nakayama E; Robinson WH; Parnes JR
    J Immunol; 1995 Mar; 154(6):2743-52. PubMed ID: 7876545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occupancy of CD72 (the CD5 counterstructure) enhances interleukin-4-dependent CD23 expression in resting B lymphocytes.
    Katira A; Kamal M; Gordon J
    Immunology; 1992 Jul; 76(3):422-6. PubMed ID: 1388135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of peripheral B cell tolerance by CD72 in a murine model.
    Li DH; Winslow MM; Cao TM; Chen AH; Davis CR; Mellins ED; Utz PJ; Crabtree GR; Parnes JR
    Arthritis Rheum; 2008 Oct; 58(10):3192-204. PubMed ID: 18821699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Lyb-2 homolog CD72 is a marker for progenitor B-cell leukemias.
    Schwarting R; Castello R; Moldenhauer G; Pezzutto A; von Hoegen I; Ludwig WD; Parnes JR; Dörken B
    Am J Hematol; 1992 Nov; 41(3):151-8. PubMed ID: 1384316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-cell co-receptor CD72 is expressed on NK cells and inhibits IFN-gamma production but not cytotoxicity.
    Alcón VL; Luther C; Balce D; Takei F
    Eur J Immunol; 2009 Mar; 39(3):826-32. PubMed ID: 19197938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes.
    Venkataraman C; Muthusamy N; Muthukkumar S; Bondada S
    J Immunol; 1998 Apr; 160(7):3322-9. PubMed ID: 9531290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies.
    Hasbold J; Johnson-Léger C; Atkins CJ; Clark EA; Klaus GG
    Eur J Immunol; 1994 Aug; 24(8):1835-42. PubMed ID: 7519998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity.
    Cerutti A; Trentin L; Zambello R; Sancetta R; Milani A; Tassinari C; Adami F; Agostini C; Semenzato G
    J Immunol; 1996 Sep; 157(5):1854-62. PubMed ID: 8757302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An anti-CD72 immunotoxin against therapy-refractory B-lineage acute lymphoblastic leukemia.
    Myers DE; Uckun FM
    Leuk Lymphoma; 1995 Jun; 18(1-2):119-22. PubMed ID: 8580813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.